After blood clots – Denmark and Norway suspend AstraZeneca vaccinations
Because severe cases of blood clots have occurred in some of the vaccinated, Denmark and Norway will initially stop vaccinating AstraZeneca’s vaccine. No such step is planned in Germany, according to the Ministry of Health.
DDenmark and Norway are temporarily stopping corona vaccinations with the vaccine from the British-Swedish pharmaceutical company AstraZeneca. This is due to reports of complications from blood clots after vaccination. A 60-year-old woman who received a dose from the same batch that was also used in Austria died in Denmark. As a precaution, Austria had stopped vaccinations with this batch after one death and one illness.
Prime Minister Mette Frederiksen confirmed to reporters in front of a hospital in Herlev, Denmark that the administration of the AstraZeneca vaccine would be paused. This news is annoying because one is incredibly dependent on everyone being vaccinated. Health Minister Magnus Heunicke spoke of a precautionary measure, as did the health administration. The incidents should be thoroughly investigated, he wrote on Twitter.
In Norway, too, the head of the infectious diseases department at the Norwegian Institute for Public Health, Geir Bukholm, spoke of a “precautionary measure”. How long the vaccinations will be suspended with the agent, the institute did not initially explain. Italy announced on Thursday that it would ban vaccinations with a very specific batch of the vaccine after evidence of serious side effects.
In Germany, the Federal Ministry of Health currently sees no reason for a similar step. “As things stand, there is still no evidence that the death in Denmark is causally related to a corona vaccination,” said a ministry spokesman on Thursday. “The European drug authorities are currently investigating the case.”
According to the Danish authorities, the stop will initially last 14 days, after which they will see how things continue. It is important to underline that the AstraZeneca vaccine is not rejected, but that its administration is paused. It is well documented that the drug is both safe and effective. However, one has to respond to reports of possible serious side effects.
According to the European Medicines Agency (EMA), the risk of blood clots does not increase with a corona vaccination. According to previous knowledge, “the number of thromboembolic events in vaccinated people is not higher than in the general population,” said the EMA at the request of the AFP news agency.
In the EU country Denmark with its 5.8 million inhabitants, around 560,000 people have received their first corona vaccination dose so far, and almost 220,000 also their second. So far, around 142,000 people have got their first stitch with the AstraZeneca fabric. The vaccine from Pfizer / Biontech was used in more than 70 percent of the vaccinations administered to date, and in four percent that from Moderna. The vaccination campaign in Denmark started more quickly than in Germany and most other European countries.